The rs9939609 gene variant in FTO modified the metabolic response of weight loss after a 3-month intervention with a hypocaloric diet

Journal of Investigative Medicine

Volumn 61, Issue 1, 2013, Pages 22-26

  De Luis, Daniel Antonio ^a   Aller, Rocío ^a   Conde, Rosa ^a   Izaola, Olatz ^a   Sagrado, Manuel Gonzalez ^a   Sanz, Javier Castrodeza ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Adipokines; Hypocaloric diet; Obesity; Rs9939609 gene variant

Indexed keywords

ADIPOCYTOKINE; INSULIN; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; DNA POLYMORPHISM; FEMALE; FOLLOW UP; FTO GENE; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN BLOOD LEVEL; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; METABOLISM; PROSPECTIVE STUDY; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; AGED; CALORIC RESTRICTION; DIET, FAT-RESTRICTED; DIET, REDUCING; FEMALE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; PROTEINS; TIME FACTORS; WEIGHT LOSS;

EID: 84873628546     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e318276161d     Document Type: Article

References (38)

1. Hinney A, Nguyen TT, Scherag A, et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS One. 2007;2:e1361.
2. Villalobos-Comparan M, Teresa Flores-Dorantes M, Teresa Villarreal-Molina M, et al. The FTO gene is associated with adulthood obesity in the Mexican population. Obesity (Silver Spring). 2008;16:2296-2301.
3. Song Y, You NC, Hsu YH, et al. FTO polymorphisms are associated with obesity but not diabetes risk in postmenopausal women. Obesity (Silver Spring). 2008;16:2472-2480.
4. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889-894.
5. Hakanen M, Raitakari OT, Lehtimaki T, et al. FTO genotype is associated with body mass index after the age of 7 years but not with energy intake or leisure-time physical activity. J Clin Endocrinol Metab. 2009;94:1281-1287.
6. Muller TD, Hinney A, Scherag A, et al. Fat mass and obesity associated gene (FTO): no significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German obese children and adolescents. BMC Med Genet. 2008;9:85.
7. Franks PW, Jablonski KA, Delahanty LM, et al. Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia. 2008;51:2214-2223.
8. Lappalainen TJ, Tolppanen AM, Kolehmainen M, et al. The common variant in the FTO gene did not modify the effect of lifestyle changes on body weight: the Finnish Diabetes Prevention Study. Obesity (Silver Spring). 2009;17:832-836.
9. Razquin C, Martinez JA, Martinez-Gonzalez MA, et al. A 3-year intervention with a Mediterranean diet modified the association between the rs9939609 gene variant in FTO and body weight changes. Int J Obes (Lond). 2010;34:266-272.
10. Grau G. Macronutrient-specific effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet among obese Europeans. Int J Obes (Lond). 2010;33:1227-1234.
11. den Hoed M, Westerterp-Plantenga MS, Bouwman FG, et al. Postprandial responses in hunger and satiety are associated with the rs9939609 single nucleotide polymorphism in FTO. Am J Clin Nutr. 2009;90:1426-1432.
12. Matsuda M, Shimomura I, Sata M. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem. 2002;277:37487-37491.
13. Kumada M, Kihara S, Sumitsuji S. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003;23:85-89.
14. Shimomoura I, Hammer RE, Ikemoto S. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 1999;401:73-76.
15. Steppan CM, Bailey ST, Bhat S. The hormone resistin links obesity to diabetes. Nature. 2001;409:307-312.
16. Matsuzawa Y. Adipocytokines: emerging therapeutic targets. Curr Atheroscler Rep. 2005;7:58-62.
17. Mataix J, Mañas M. Tablas de composición de alimentos españoles. Ed: University of Granada; 2003.
18. Duart MJ, Arroyo CO, Moreno JL. Validation of an insulin model for the reactions in RIA. Clin Chem Lab Med. 2002;40:1161-1167.
19. Mathews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-414.
20. Pfutzner A, Langefeld M, Kunt T, et al. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab. 2003;49:571-576.
21. Meier U, Gressner M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, Ghrelin, adiponectin, and resistin. Clin Chem. 2004;50:1511-1525.
22. Suominen P. Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem. 2004;50:219-221.
23. Lubrano V, Cocci F, Battaglia D, et al. Usefulness of high Ysensitivity IL6 measurement for clinical characterization of patients with coronary artery disease. J Clin Lab Anal. 2005;19:110-114.
24. Pichard C, Slosman D, Hirschel B, et al. Bioimpedance analysis: an improved method for nutritional follow up. Clin Res. 1993;41:53.
25. Scuteri A, Sanna S, Chen WM, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3:e115.
26. Reinehr T, Hinney A, Toschke AM, et al. Aggravating effect of INSIG2 and FTO on overweight reduction in a one-year lifestyle intervention. Arch Dis Child. 2009;94:965-967.
27. Dlouha D, Suchanek P, Lanska V, et al. Body mass index change in females after short time life style intervention is not dependent on the FTO polymorphisms. Physiol Res. 2011;60:199-202.
28. Qi L, Kang K, Zhang C, et al. Fat mass- and obesity-associated (FTO) gene variant is associated with obesity: longitudinal analyses in two cohort studies and functional test. Diabetes. 2008;57:3145-3151.
29. de Luis DA, Aller R, Izaola O, et al. Influence of lys656Asn polymorphism of leptin receptor gene on leptin response secondary to two hypocaloric diets: a randomized clinical trial. Ann Nutr Metab. 2008;52:209-214.
30. de Luis DA, Aller R, Izaola O, et al. Modulation of insulin concentrations and metabolic parameters in obese patients by -55CT polymorphism of the UCP3 gene secondary to two hypocaloric diets. Horm Metab Res. 2009;41:62-66.
31. de Luis DA, Sagrado MG, Aller R, et al. Effects of C358A missense polymorphism of degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets. Metabolism. 2010;59:1387-1392.
32. Dina C, Meyre D, Gallina S. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;3:724-726.
33. Samaras K, Botelho N, Chisholm R, et al. Subcutaneous and visceral adipose tissue FTO gene expression and adiposity, insulin action, glucose metabolism, and inflammatory adipokines in type 2 diabetes mellitus and in Health. Obes Surg. 2010;20:108-113.
34. Andreasesn CH, Stender Petersen KL, Mogensen MS, et al. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes. 2008;57:95-101.
35. Zabena C, Gonzalez Sanchez JL, Martinez Larrad MT. The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients. Obes Surg. 2008;19:87-95.
36. Zimmermann E, Skogstrand K, Hougaard D, et al. Influences of the common FTO rs9939609 variant on inflammatory markers throughout a broad range of BMI. PLoS One. 2011;6:e15958-159619.
37. Terra X, Auguet T, Porras J, et al. Anti-inflammatory profile of FTO gene expression in adipose tissues from morbidly obese women. Cell Physiol Biochem. 2010;26:1041-1050.
38. Wehr E, Schweighofer N, Möller R, et al. Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndrome. Metabolism. 2010;59:575-580.